Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$5,846,022
+$1,512,986 QoQ
Shares Held
4,874
+3.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
#1,590
of 4,605 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Stratos Wealth Advisors, LLC holds $23,629,551 across 10 Drug Manufacturers - General names. LLY ranks #1 (24.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
4,874 | $5,846,022 | |
| 2 | ABBV |
AbbVie Inc.
|
15,684 | $3,946,721 | |
| 3 | MRK |
Merck & Co., Inc.
|
24,837 | $3,191,554 | |
| 4 | JNJ |
Johnson & Johnson
|
11,189 | $2,841,670 | |
| 5 | AMGN |
Amgen Inc
|
6,512 | $2,358,125 | |
| 6 | PFE |
Pfizer Inc
|
76,265 | $1,836,461 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
29,183 | $1,681,524 | |
| 8 | NVS |
Novartis AG
|
8,587 | $1,345,754 |
All Filings in LLY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,846,022 | 4,874 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $4,333,036 | 4,711 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $4,069,813 | 3,787 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $2,858,961 | 3,747 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,789,937 | 3,579 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $19,773,937 | 23,942 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $3,064,840 | 3,970 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $4,040,772 | 4,561 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $24,003,434 | 26,512 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $20,720,186 | 26,634 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $3,047,505 | 5,228 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $2,631,399 | 4,899 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $2,417,591 | 5,155 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $1,754,189 | 5,108 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $2,099,555 | 5,739 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $1,700,174 | 5,258 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $1,752,463 | 5,405 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $1,382,021 | 4,826 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $1,067,866 | 3,866 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $826,234 | 3,576 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $982,575 | 4,281 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $437,719 | 2,343 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $231,479 | 1,371 | Shares | Sole | 2021-01-29 | |
| No filing history on record for this holder in this stock. | ||||||